Cambridge Investment Research Advisors, Inc. Pro Phase Labs, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$8.78 - $12.47 $49,887 - $70,854	5,682 Added 22.67%	30,744 $296,000
Q3 2022 Oct 17, 2022	BUY	$8.96 - $14.7 $106,193 - $174,224	11,852 Added 89.72%	25,062 $0
Q2 2022 Jul 13, 2022	BUY	$6.52 - $13.24 $86,129 - $174,900	13,210 New	13,210 $167,000

Others Institutions Holding PRPH

# of Institutions

Shares Held

1.71M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

656K
Shares

$413,246
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

215K
Shares

$135,519
0.0% of portfolio
High Tower Advisors, LLC Chicago, IL

179K
Shares

$112,798
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

161K
Shares

$101,263
0.0% of portfolio
Perritt Capital Management Inc Chicago, IL

82.9K
Shares

$52,247
0.11% of portfolio

View Full List

About ProPhase Labs, Inc.

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $10.1M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

More about PRPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account